Page last updated: 2024-10-22

anthralin and Erythema

anthralin has been researched along with Erythema in 58 studies

Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.

Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.

Research Excerpts

ExcerptRelevanceReference
"The influence of short-contact anthralin on the therapeutic effect of ultraviolet B irradiation (Sylvania UV-21 tubes) was investigated with the half-body comparison method in fifteen outpatients with plaque-type psoriasis."9.06Effect of short-contact anthralin therapy on ultraviolet B irradiation of psoriasis. ( Boer, J; Smeenk, G, 1986)
"Recent trends in psoriasis therapy favor using lower-strength anthralins."9.05The effectiveness of low-strength anthralin in psoriasis. A paired comparison study. ( Dawkins, L; Hernandez, AD; Josephs, JA; Marley, WM, 1982)
"1 The effect of topical arachidonic acid on anthralin inflammation was studied using sequential measurements of erythema (reflectance photometry) and oedema (calipers)."7.67Effect of arachidonic acid on anthralin inflammation. ( Lawrence, CM; Shuster, S, 1987)
"The effect of tar on anthralin-induced erythema was epicutaneously tested in ten patients."7.67[Effect of various kinds of tar and tar concentrations on anthralin erythema]. ( Mahrle, G; Schulze, HJ; Steigleder, GK; Wemmer, U, 1986)
"Eighteen patients with chronic plaque psoriasis were investigated in two groups to determine the optimal contact time for the application of 2% anthralin, within the range immediate removal to removal at 20 min."7.67Short contact anthralin in the treatment of psoriasis: a study of different contact times. ( MacDonald, KJ; Marks, J, 1986)
"Anthralin erythema dose-response curves were drawn for thirty adult patients of various skin types who had chronic plaque psoriasis."7.66Relationship between skin type and erythemal response to anthralin. ( Greaves, MW; Maurice, PD, 1983)
"Anthralin has been applied in low and high concentrations with and without UV-irradiation in the treatment of psoriasis (Schauder & Mahrle, 1982a,b)."7.66Anthralin inflammation versus UV-erythema in psoriatics. ( Mahrle, G; Schauder, S, 1983)
"Anthralin was applied to psoriatic plaques on one side in the following fashion: anthralin 0."6.69A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center. ( Dutz, JP; Lui, H, 1998)
" Safety was determined from reports of adverse events and blood chemistry analysis."6.69The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol. ( Hutchinson, PE; Marks, R; White, J, 2000)
"The influence of short-contact anthralin on the therapeutic effect of ultraviolet B irradiation (Sylvania UV-21 tubes) was investigated with the half-body comparison method in fifteen outpatients with plaque-type psoriasis."5.06Effect of short-contact anthralin therapy on ultraviolet B irradiation of psoriasis. ( Boer, J; Smeenk, G, 1986)
"Recent trends in psoriasis therapy favor using lower-strength anthralins."5.05The effectiveness of low-strength anthralin in psoriasis. A paired comparison study. ( Dawkins, L; Hernandez, AD; Josephs, JA; Marley, WM, 1982)
"Anthralin is a safe, effective treatment for psoriasis, but its efficacy is hampered by the side-effects of irritation and staining of the uninvolved skin."3.70The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration. ( Friedmann, PS; Parslew, R, 1999)
"The irritation response to anthralin was studied using the chamber-testing technique in 17 patients with vitiligo."3.67Increased anthralin irritation response in vitiliginous skin. ( Bos, JD; Buehre, Y; Das, PK; Krieg, SR; Pavel, S; Siddiqui, AH; Westerhof, W, 1989)
"1 The effect of topical arachidonic acid on anthralin inflammation was studied using sequential measurements of erythema (reflectance photometry) and oedema (calipers)."3.67Effect of arachidonic acid on anthralin inflammation. ( Lawrence, CM; Shuster, S, 1987)
"In 44 patients with chronic plaque psoriasis anthralin therapy was used as high-strength short-contact therapy in a bilateral comparison of anthralin versus 5% crude coal tar-anthralin combination."3.67Combined tar-anthralin versus anthralin treatment lowers irritancy with unchanged antipsoriatic efficacy. Modifications of short-contact therapy and Ingram therapy. ( Mahrle, G; Schauder, S; Schulze, HJ; Steigleder, GK, 1987)
"The effect of tar on anthralin-induced erythema was epicutaneously tested in ten patients."3.67[Effect of various kinds of tar and tar concentrations on anthralin erythema]. ( Mahrle, G; Schulze, HJ; Steigleder, GK; Wemmer, U, 1986)
"Eighteen patients with chronic plaque psoriasis were investigated in two groups to determine the optimal contact time for the application of 2% anthralin, within the range immediate removal to removal at 20 min."3.67Short contact anthralin in the treatment of psoriasis: a study of different contact times. ( MacDonald, KJ; Marks, J, 1986)
"The effect of topical clobetasol propionate and a 1% topical indomethacin gel which could inhibit UV erythema was measured on anthralin inflammation by change in skin-fold thickness and erythema."3.67Mechanism of anthralin inflammation. I. Dissociation of response to clobetasol and indomethacin. ( Lawrence, CM; Shuster, S, 1985)
"Anthralin erythema dose-response curves were drawn for thirty adult patients of various skin types who had chronic plaque psoriasis."3.66Relationship between skin type and erythemal response to anthralin. ( Greaves, MW; Maurice, PD, 1983)
"In 20 volunteers, we were able to demonstrate experimentally that side-effects of anthralin application on healthy skin development of erythema and pigmentation, can be significantly reduced in a short contact therapy, in comparison to a longterm treatment."3.66[Side effects of anthralin and its 2 main impurities on healthy skin]. ( Puschmann, M; Schmersahl, P, 1983)
"Anthralin has been applied in low and high concentrations with and without UV-irradiation in the treatment of psoriasis (Schauder & Mahrle, 1982a,b)."3.66Anthralin inflammation versus UV-erythema in psoriatics. ( Mahrle, G; Schauder, S, 1983)
"Anthralin was applied to psoriatic plaques on one side in the following fashion: anthralin 0."2.69A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center. ( Dutz, JP; Lui, H, 1998)
" We used low-dose narrow-band UVB phototherapy, combined with balneotherapy, short-contact anthralin, liquor carbonis detergens and calcipotriol for treatment of psoriatic patients in our day care centre."2.69Low-dose narrow-band UVB phototherapy combined with topical therapy is effective in psoriasis and does not inhibit systemic T-cell activation. ( Bos, JD; de Rie, MA; Out, TA, 1998)
" Safety was determined from reports of adverse events and blood chemistry analysis."2.69The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol. ( Hutchinson, PE; Marks, R; White, J, 2000)
" Our purpose is to compare the rates of adverse events associated with different topical psoriasis treatments."2.42A systematic review of adverse effects associated with topical treatments for psoriasis. ( Bruner, CR; Feldman, SR; Fleischer, AB; Ventrapragada, M, 2003)
"Anthralin was first synthesized in 1916."2.36Anthralin: historical and current perspectives. ( Andre, P; Ashton, RE; Lowe, NJ; Whitefield, M, 1983)
"Anthralin and UVB were then applied to the gel-treated skin and the anthralin- and UVB-induced erythema and oedema were measured at 2, 6, 24 and 48 h using Harpenden callipers and a reflectance erythrometer."1.28The effect of indomethacin on anthralin inflammation. ( Lawrence, C; Ramsay, B; Rice, N, 1992)
"8 of these 13 reacted with blister formation after exposure to 0."1.27Irritant potential of dithranol. ( Haustein, UF; Lohrisch, I, 1986)

Research

Studies (58)

TimeframeStudies, this research(%)All Research%
pre-199040 (68.97)18.7374
1990's14 (24.14)18.2507
2000's4 (6.90)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruner, CR1
Feldman, SR1
Ventrapragada, M1
Fleischer, AB1
HEITE, HJ1
KLEINHANS, D1
Waterston, K1
Naysmith, L1
Rees, JL2
Finnen, MJ1
Lawrence, CM3
Shuster, S3
Mustakallio, KK4
Brandt, H1
Kolari, PJ2
Göransson, AM1
Ashton, RE1
Andre, P1
Lowe, NJ1
Whitefield, M2
Farber, EM1
Maurice, PD1
Greaves, MW2
Puschmann, M2
Barr, RM1
Misch, KJ1
Hensby, CN2
Mallet, AI1
Schulze, HJ3
Kingston, T1
Marks, R2
Schmersahl, P1
Schauder, S2
Mahrle, G3
Marley, WM1
Hernandez, AD1
Josephs, JA1
Dawkins, L1
Misch, K1
Davies, M1
Greaves, M1
Coutts, A1
Juhlin, L1
Stüttgen, G1
Flesch, U1
Siebel, JT1
van der Valk, PG3
Zarafonitis, G1
Snater, E2
Janssen, EA1
van de Kerkhof, PC5
Healy, E1
Reynolds, NJ1
Smith, MD1
Campbell, C1
Farr, PM2
Shenoy, SD1
Wali, I1
Srinivas, CR1
Schiavi, ME1
Belletti, B1
Seidenari, S1
Dutz, JP1
Lui, H1
de Rie, MA1
Out, TA1
Bos, JD2
Prins, M1
Swinkels, OQ1
Kolkman, EG1
Wuis, EW1
Hekster, YA1
Parslew, R1
Friedmann, PS1
Hutchinson, PE1
White, J1
Fluhr, JW1
Kuss, O1
Diepgen, T1
Lazzerini, S1
Pelosi, A1
Gloor, M2
Berardesca, E1
Gehring, W1
Ghyczy, M1
Scheer, T1
Röding, J1
Ramsay, B1
Rice, N1
Lawrence, C1
Zackheim, HS1
Timmerman, MG2
Mier, PD1
de Mare, S1
Calis, N1
den Hartog, G1
van Erp, PE1
Fokkink, HJ1
Christensen, OB1
Holst, R1
Hradil, E1
Brolund, L1
Westerhof, W1
Buehre, Y1
Pavel, S1
Das, PK1
Krieg, SR1
Siddiqui, AH1
Diffey, BL1
Marks, JM1
Kudejko, J1
Lecewicz-Toruń, B1
Chibowska, M1
Tyszlukiewicz, D1
Kuczyńska, L1
Nestorowicz, B1
Steigleder, GK2
Shroot, B1
Chatelus, A1
Cavey, D1
Allec, J1
Maignan, J1
Richter, G1
Barth, J2
Boer, J1
Smeenk, G1
Wemmer, U1
Young, E1
Haustein, UF1
Lohrisch, I1
Hanhijärvi, H1
Nevalainen, T1
Männistö, P1
MacDonald, KJ1
Marks, J1
Gupta, AK1
Ellis, CN1
Goldfarb, MT1
Voorhees, JJ1
Heller, G1
Wozel, G1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Spray® and Vectical Ointment® in the Treatment of Plaque Psoriasis[NCT01205880]Phase 412 participants (Actual)Interventional2009-12-31Completed
Effect of an Emollient Cream Containing 0.5% Cannabidiol and 1% Hemp Oil in the Hydration and Erythema of the Skin[NCT04045314]49 participants (Actual)Interventional2019-08-15Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for anthralin and Erythema

ArticleYear
A systematic review of adverse effects associated with topical treatments for psoriasis.
    Dermatology online journal, 2003, Volume: 9, Issue:1

    Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal Tar; Dermatologic Agen

2003
Anthralin: historical and current perspectives.
    Journal of the American Academy of Dermatology, 1983, Volume: 9, Issue:2

    Topics: Anthracenes; Anthralin; Cell Division; Chemistry; Cyclic AMP; Cyclic GMP; DNA Replication; Drug Admi

1983

Trials

15 trials available for anthralin and Erythema

ArticleYear
Physiological variation in the erythemal response to ultraviolet radiation and photoadaptation.
    The Journal of investigative dermatology, 2004, Volume: 123, Issue:5

    Topics: Adaptation, Physiological; Adolescent; Adult; Anthralin; Anti-Inflammatory Agents; Dose-Response Rel

2004
Inhibition of dithranol inflammation by free-radical scavengers.
    Lancet (London, England), 1984, Nov-17, Volume: 2, Issue:8412

    Topics: Administration, Topical; Adult; Aged; Anthracenes; Anthralin; Butylated Hydroxyanisole; Diterpenes;

1984
The effectiveness of low-strength anthralin in psoriasis. A paired comparison study.
    Archives of dermatology, 1982, Volume: 118, Issue:11

    Topics: Administration, Oral; Anthracenes; Anthralin; Double-Blind Method; Erythema; Female; Humans; Male; P

1982
Transepidermal water vapour loss is not increased during and following dithranol irritation.
    The British journal of dermatology, 1995, Volume: 132, Issue:6

    Topics: Adult; Anthralin; Colorimetry; Epidermis; Erythema; Female; Humans; Male; Skin; Time Factors; Water

1995
A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
    International journal of dermatology, 1998, Volume: 37, Issue:1

    Topics: Administration, Topical; Adolescent; Adult; Aged; Ambulatory Care Facilities; Anthralin; Anti-Inflam

1998
Low-dose narrow-band UVB phototherapy combined with topical therapy is effective in psoriasis and does not inhibit systemic T-cell activation.
    Dermatology (Basel, Switzerland), 1998, Volume: 196, Issue:4

    Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Balneology; C

1998
Skin irritation by dithranol cream. A blind study to assess the role of the cream formulation.
    Acta dermato-venereologica, 1998, Volume: 78, Issue:4

    Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Colorimetry; Erythema; Female;

1998
The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol.
    Dermatology (Basel, Switzerland), 2000, Volume: 201, Issue:2

    Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Calcitriol; Eczema; Emulsions;

2000
The effect of clobetasol-17-propionate and crude coal tar on dithranol-induced inflammation. A clinical and biochemical study.
    Acta dermato-venereologica, 1990, Volume: 70, Issue:5

    Topics: Adolescent; Adult; Alkaline Phosphatase; Anthralin; Clobetasol; Coal Tar; Drug Therapy, Combination;

1990
The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams.
    Skin pharmacology : the official journal of the Skin Pharmacology Society, 1988, Volume: 1, Issue:4

    Topics: Adolescent; Adult; Anthralin; DNA; Double-Blind Method; Erythema; Female; Flow Cytometry; Humans; Ke

1988
Clinical response and side-effects in the treatment of psoriasis with UV-B and -A novel dithranol formulation.
    Acta dermato-venereologica. Supplementum, 1989, Volume: 146

    Topics: Adolescent; Adult; Aged; Anthralin; Combined Modality Therapy; Drug Compounding; Erythema; Female; H

1989
Phototherapy and dithranol treatment of psoriasis: new lamps for old.
    British medical journal (Clinical research ed.), 1987, Jan-24, Volume: 294, Issue:6566

    Topics: Adolescent; Adult; Anthralin; Clinical Trials as Topic; Combined Modality Therapy; Erythema; Female;

1987
[Treatment of psoriasis with erythema dose of cygnoline and irradiation with ultraviolet rays].
    Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 1986, Volume: 41

    Topics: Adolescent; Adult; Anthralin; Erythema; Female; Humans; Male; Middle Aged; Psoriasis; PUVA Therapy;

1986
Effect of short-contact anthralin therapy on ultraviolet B irradiation of psoriasis.
    Journal of the American Academy of Dermatology, 1986, Volume: 15, Issue:2 Pt 1

    Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Combined Modality Therapy; Erythema; Female; Humans

1986
Treatment of psoriasis with dithranol cream compared with dithranol paste.
    Dermatologica, 1986, Volume: 173, Issue:6

    Topics: Administration, Topical; Anthralin; Dosage Forms; Erythema; Evaluation Studies as Topic; Humans; Pso

1986

Other Studies

41 other studies available for anthralin and Erythema

ArticleYear
[On cignolin erythema swelling in some dermatoses].
    Archiv fur klinische und experimentelle Dermatologie, 1961, Volume: 212

    Topics: Anthralin; Dermatology; Edema; Erythema; Skin Diseases

1961
Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues.
    Acta dermato-venereologica, 1980, Volume: 60, Issue:2

    Topics: Anthracenes; Anthralin; Drug Eruptions; Edema; Erythema; Humans; Psoriasis; Skin; Structure-Activity

1980
Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
    Acta dermato-venereologica, 1983, Volume: 63, Issue:3

    Topics: Anthracenes; Anthralin; Erythema; Humans; Irritants; Skin; Skin Tests

1983
Irritation and staining by dithranol (anthralin) and related compounds. IV. Visual estimation of erythema compared with contact thermometry and laser Doppler flowmetry.
    Acta dermato-venereologica, 1983, Volume: 63, Issue:6

    Topics: Anthracenes; Anthralin; Dose-Response Relationship, Drug; Erythema; Humans; Lasers; Psoriasis; Rheol

1983
Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
    Acta dermato-venereologica, 1984, Volume: 64, Issue:2

    Topics: Anthracenes; Anthralin; Drug Administration Schedule; Erythema; Humans; Psoriasis; Skin; Staining an

1984
Topical treatment of psoriasis with dithranol.
    Acta dermato-venereologica. Supplementum, 1984, Volume: 112

    Topics: Administration, Topical; Anthracenes; Anthralin; Combined Modality Therapy; Drug Administration Sche

1984
Relationship between skin type and erythemal response to anthralin.
    The British journal of dermatology, 1983, Volume: 109, Issue:3

    Topics: Adult; Anthracenes; Anthralin; Dose-Response Relationship, Drug; Erythema; Female; Humans; Male; Pso

1983
[Anthralin erythema: effect of concentration, contact time, oxidation products and corticosteroids. Clinical, reflection photometry and electron microscopy studies].
    Zeitschrift fur Hautkrankheiten, 1983, Nov-15, Volume: 58, Issue:22

    Topics: Adrenal Cortex Hormones; Anthracenes; Anthralin; Erythema; Humans; Microscopy, Electron; Photometry;

1983
Arachidonic acid and prostaglandin levels in dithranol erythema: time course study.
    British journal of clinical pharmacology, 1983, Volume: 16, Issue:6

    Topics: Adult; Aged; Anthracenes; Anthralin; Arachidonic Acids; Erythema; Female; Humans; Male; Middle Aged;

1983
[Suppression of cignolin-induced erythema by tar].
    Zeitschrift fur Hautkrankheiten, 1984, May-15, Volume: 59, Issue:10

    Topics: Anthracenes; Anthralin; Coal Tar; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Combin

1984
Irritant reactions to dithranol in normal subjects and psoriatic patients.
    The British journal of dermatology, 1983, Volume: 108, Issue:3

    Topics: Anthracenes; Anthralin; Dose-Response Relationship, Drug; Erythema; Humans; Indomethacin; Irritants;

1983
[Side effects of anthralin and its 2 main impurities on healthy skin].
    Zeitschrift fur Hautkrankheiten, 1983, Mar-15, Volume: 58, Issue:6

    Topics: Anthracenes; Anthralin; Anthraquinones; Dose-Response Relationship, Drug; Erythema; Humans; Oxidatio

1983
Anthralin inflammation versus UV-erythema in psoriatics.
    The British journal of dermatology, 1983, Volume: 109 Suppl 25

    Topics: Anthracenes; Anthralin; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Ery

1983
Pharmacological studies of anthralin erythema.
    The British journal of dermatology, 1981, Volume: 105 Suppl 20

    Topics: Anthracenes; Anthralin; Aspirin; Betamethasone Valerate; Chlorpheniramine; Erythema; Female; Humans;

1981
Factors influencing anthralin erythema.
    The British journal of dermatology, 1981, Volume: 105 Suppl 20

    Topics: Anthracenes; Anthralin; Erythema; Humans; Psoriasis; Skin; Ultraviolet Therapy

1981
Thermographic analyses of anthralin and UV-B exposed human skin.
    The British journal of dermatology, 1981, Volume: 105 Suppl 20

    Topics: Anthracenes; Anthralin; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Ery

1981
Quantification of biophysical properties of the skin.
    Current problems in dermatology, 1995, Volume: 22

    Topics: Anthralin; Biophysical Phenomena; Biophysics; Body Water; Dermatitis, Irritant; Erythema; Humans; Sk

1995
Dissociation of erythema and p53 protein expression in human skin following UVB irradiation, and induction of p53 protein and mRNA following application of skin irritants.
    The Journal of investigative dermatology, 1994, Volume: 103, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anthralin; Dermatitis, Irritant; Erythema; Female; Gene Expression R

1994
Dithranol-induced erythema sparing hypopigmented lesions of pityriasis versicolor.
    Contact dermatitis, 1993, Volume: 28, Issue:4

    Topics: Adult; Anthralin; Erythema; Humans; Male; Tinea Versicolor

1993
Ultrasound description and quantification of irritant reactions induced by dithranol at different concentrations. A comparison with visual assessment and colorimetric measurements.
    Contact dermatitis, 1996, Volume: 34, Issue:4

    Topics: Administration, Topical; Adolescent; Adult; Analysis of Variance; Anthralin; Anti-Inflammatory Agent

1996
The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration.
    The British journal of dermatology, 1999, Volume: 141, Issue:3

    Topics: Adaptation, Physiological; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Case-Contro

1999
Testing for irritation with a multifactorial approach: comparison of eight non-invasive measuring techniques on five different irritation types.
    The British journal of dermatology, 2001, Volume: 145, Issue:5

    Topics: Adult; Analysis of Variance; Anthralin; Calorimetry; Dermatitis, Irritant; Erythema; Female; Humans;

2001
Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes.
    Arzneimittel-Forschung, 1992, Volume: 42, Issue:7

    Topics: Adult; Anthralin; Colorimetry; Drug Carriers; Erythema; Female; Humans; Liposomes; Male; Petrolatum;

1992
The effect of indomethacin on anthralin inflammation.
    The British journal of dermatology, 1992, Volume: 126, Issue:3

    Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Dermatitis, Contact; Edema; Erythema; F

1992
Evaluation of anthralin for mycosis fungoides.
    Journal of the American Academy of Dermatology, 1992, Volume: 27, Issue:1

    Topics: Adult; Aged; Anthralin; Erythema; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Ointments; S

1992
Studies on the time course of dithranol-induced inflammation by quantification of alkaline phosphatase.
    Acta dermato-venereologica, 1990, Volume: 70, Issue:1

    Topics: Adult; Alkaline Phosphatase; Anthralin; Biopsy; Erythema; Female; Free Radicals; Humans; Male; Patch

1990
Irritancy of dithranol in normally pigmented and depigmented skin of patients with vitiligo.
    Acta dermato-venereologica, 1989, Volume: 69, Issue:3

    Topics: Adult; Anthralin; Dose-Response Relationship, Drug; Erythema; Female; Humans; Irritants; Male; Middl

1989
Increased anthralin irritation response in vitiliginous skin.
    Archives of dermatological research, 1989, Volume: 281, Issue:1

    Topics: Adult; Anthralin; Cell Count; Erythema; Female; Humans; Irritants; Male; Middle Aged; Patch Tests; S

1989
Effect of arachidonic acid on anthralin inflammation.
    British journal of clinical pharmacology, 1987, Volume: 24, Issue:2

    Topics: Administration, Topical; Adult; Aged; Anthralin; Arachidonic Acid; Arachidonic Acids; Diterpenes; Ed

1987
Combined tar-anthralin versus anthralin treatment lowers irritancy with unchanged antipsoriatic efficacy. Modifications of short-contact therapy and Ingram therapy.
    Journal of the American Academy of Dermatology, 1987, Volume: 17, Issue:1

    Topics: Administration, Topical; Anthralin; Coal Tar; Drug Combinations; Erythema; Humans; Psoriasis; Ultrav

1987
In vitro and in vivo antiinflammatory activities of C10 substituted anthralin derivatives.
    Agents and actions, 1987, Volume: 21, Issue:3-4

    Topics: Animals; Anthralin; Anti-Inflammatory Agents, Non-Steroidal; Chemotaxis, Leukocyte; Dermatitis, Cont

1987
[Potential factors influencing dithranol erythema].
    Dermatologische Monatschrift, 1986, Volume: 172, Issue:5

    Topics: Adult; Anthracenes; Anthralin; Erythema; Female; Humans; Male; Patch Tests; Psoriasis; Skin

1986
[Effect of various kinds of tar and tar concentrations on anthralin erythema].
    Zeitschrift fur Hautkrankheiten, 1986, Jun-15, Volume: 61, Issue:12

    Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Coal Tar; Dose-Response Relationship, Drug; Erythem

1986
Irritant potential of dithranol.
    Dermatologica, 1986, Volume: 173, Issue:6

    Topics: Anthralin; Blister; Dermatitis, Contact; Dose-Response Relationship, Drug; Drug Incompatibility; Ery

1986
Degradation of anthralin by coal tar.
    Journal of the American Academy of Dermatology, 1987, Volume: 16, Issue:3 Pt 1

    Topics: Anthralin; Coal Tar; Drug Synergism; Erythema; Humans

1987
A six month dermal irritation test with anthralins in the Göttingen miniature swine.
    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement, 1985, Volume: 8

    Topics: Animals; Anthracenes; Anthralin; Erythema; Female; Male; Random Allocation; Skin; Swine; Swine, Mini

1985
Short contact anthralin in the treatment of psoriasis: a study of different contact times.
    The British journal of dermatology, 1986, Volume: 114, Issue:2

    Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Chronic Disease; Color; Drug Administration

1986
Woronoff ring during anthralin therapy for psoriasis.
    Archives of dermatology, 1986, Volume: 122, Issue:3

    Topics: Anthracenes; Anthralin; Erythema; Humans; Middle Aged; Pigmentation Disorders; Psoriasis; Skin

1986
Mechanism of anthralin inflammation. I. Dissociation of response to clobetasol and indomethacin.
    The British journal of dermatology, 1985, Volume: 113, Issue:1

    Topics: Adult; Aged; Anthracenes; Anthralin; Betamethasone; Clobetasol; Dermatitis, Contact; Edema; Erythema

1985
[Reduction of erythema by the addition of bituminous coal tar in anthralin short-term therapy].
    Dermatologische Monatschrift, 1985, Volume: 171, Issue:11

    Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Coal Tar; Drug Therapy, Combination; Erythema; Fema

1985
[Suppression of dithranol erythema by the addition of tar in short-term therapy].
    Dermatologische Monatschrift, 1985, Volume: 171, Issue:12

    Topics: Anthracenes; Anthralin; Drug Therapy, Combination; Erythema; Humans; Psoriasis; Tars

1985